The Mulligan Law Firm is Evaluating FLEET® PHOSPHO-SODA® Alleged Injury Cases

The Mulligan Law Firm is Evaluating FLEET® PHOSPHO-SODA® Alleged Injury Cases

The Mulligan Law Firm announces that it is evaluating and investigating cases where the usage of FLEET® PHOSPHO-SODA® has allegedly led to acute kidney injuries.    

The Mulligan Law Firm (http://www.mulliganlaw.com) has started evaluating alleged acute kidney injuries related to the use of FLEET® PHOSPHO-SODA®.
On December 11, 2008, the Food & Drug Administration (FDA) stated that it would be adding a Boxed Warning to the prescription Oral Sodium Phosphate (OSP) products Visicol® and OsmoPrep®, to advise people of the potential risk of acute phosphate nephropathy (a type of acute kidney injury).

Patients routinely take OSP products to cleanse the bowel before a colonoscopy (colon examination) and other medical procedures.

The FDA stated it was equally concerned about the possible risks associated with the use of certain OSP products that can be purchased over-the-counter (OTC), including Fleet® Phospho-soda®, when used at higher doses for bowel cleansing. 

The available data did not demonstrate a risk of acute kidney injury when Fleet® Phospho-soda® was used at the lower doses for laxative use. 

However, the FDA added that: … “when used for bowel cleansing, these products have the same risks as prescription OSP products. FDA plans to amend the labeling conditions for OTC OSP products to address this concern with bowel cleansing use. In light of the continued receipt of reports of acute phosphate nephropathy, FDA is recommending that consumers not use over-the-counter OSPs for bowel cleansing.”

On the same day that the FDA released its statement, C.B. Fleet Company – the makers of Fleet® Phospho-Soda® – immediately announced a voluntary recall of the product.

If you or a loved one knows of someone potentially injured by Fleet® Phospho-soda®, you should contact The Mulligan Law Firm immediately. The firm is very interested in speaking with you, and evaluating and investigating your potential case at no cost to you.

The attorneys of The Mulligan Law Firm emphasize that in personal injury cases it is vital that steps are taken to preserve all available evidence, and to allow physicians and/or other expert witnesses to thoroughly evaluate any and all potential injuries.

Moreover, statutes of limitations require potential plaintiffs to act within certain established time-frames. Any failure or delay in contacting an attorney may result in a potential claimant losing his or her rights.

Do not delay: contact The Mulligan Law Firm today if you have questions and concerns about alleged injured from the use of Fleet® Phospho-soda®

About The Mulligan Law Firm:

The Mulligan Law Firm was formed in 1995. The firm has successfully represented thousands of individuals in a wide variety of practice areas in federal and state courts throughout the United States, and has achieved recoveries for its clients exceeding well over $600 million U.S. dollars. The firm obtained an AV rating with Martindale-Hubbell which indicates very high to preeminent legal ability and very high ethical standards as established by confidential opinions from members of the Bar.

For more information on birth defects and SSRI use and The Mulligan Law Firm, see the website: http://www.mulliganlaw.com

The Mulligan Law Firm’s Texas, California, and Florida Lawyers / Attorneys are evaluating nationwide claims. 

The Mulligan Law Firm represents clients throughout the United States in conjunction with local counsel licensed in other jurisdictions.

Contact:

Patrick J. Mulligan, Lawyer / Attorney*
Eric Gruenwald, Lawyer / Attorney**
The Mulligan Law Firm
866-529-0001, EXT. 245
214-219-9779, EXT. 245
Email:  help@mulliganlaw.com
For details about our attorneys and areas of practice, see:
http://www.mulliganlaw.com

*   Licensed in Texas & Georgia.
** Licensed in California only.

Leave a Reply